CME Activity


The Effect of Paclitaxel on Patients With Peripheral Arterial Disease: A Review of Current Literature and Best Practices

This CME Webcast will review the recent findings and literature, mechanisms of action, benefit and risks of paclitaxel, as well as discuss safety considerations in PAD applications. Speakers include Jihad A. Mustapha, MD; Michael R. | Read More

An Overview of Peripheral Neuropathy in Diabetes

How Prevalent is Neuropathy? Peripheral neuropathy is the most prevalent complication of type 2 diabetes. The 2004 National Health and Nutrition Examination Survey (NHANES) on lower extremity complications revealed that close to 10% of people with… | Read More

Remittive Therapy in the Management of Symptomatic and Nonsymptomatic Diabetic Neuropathy

Neuropathy affects 66% of patients with diabetes mellitus, of which the most common presentation is a diffuse peripheral symmetrical polyneuropathy. Only 10–20% of patients with diabetic neuropathy are affected by pain, paresthesia, or dysesthesia… | Read More